Event Honors NIH Partnership with Voices For Our Fathers Legacy Foundation

This is an excerpt from the October 11, 2024, issue of the NIH Record.  The article below was authored by Eric Bock and all photos were taken by Chia-Chi Charlie Change. The original article can be found at: https://nihrecord.nih.gov/2024/10/11/event-honors-nih-partnership-voices-our-fathers-legacy-foundation

NIH recently debuted a plaque honoring the memory of the African American men unethically treated in the U.S. Public Health Service (USPHS) Untreated Syphilis Study and the 50th anniversary of the National Research Act at the National Library of Medicine (NLM) herb garden, across from Bldg. 38, on Sept. 19.

“This plaque shines a light on the injustices of the past, not letting us forget them so they are never repeated,” said NIH Director Dr. Monica Bertagnolli during the dedication ceremony. “NIH is committed to making biomedical research inclusive and accessible for everyone.”

In 1932, the study began in Alabama. Originally called the “United States Public Health Service Study of Untreated Syphilis in the Negro Male at Tuskegee and Macon County, Alabama,” the study enrolled 625 African American men. Researchers conducting the study did not obtain informed consent and did not offer treatment, even after it was widely available.

“Much is known about the inhumane, immoral, unethical treatment of these men,” said Lillie Tyson Head, founding president of the Voices For Our Fathers Legacy Foundation, a nonprofit formed by the descendants of the men who were treated unethically in the study. “But little is known about their humanity.”

As Tyson Head noted, most of the participants were poor sharecroppers who had little time or money for doctor visits. During the growing season, they spent their time working in vegetable gardens, tending to farm animals and preparing fields for corn, beans and cotton. They had few opportunities to learn to read and write.

These men were sons, husbands, fathers and brothers. “The most important things to them were caring and providing for their families,” she said.

The study ended in 1972, after a reporter exposed it and a federal committee, which met at NIH among other locations, recommended the study be shut down. After a public outcry, the National Research Act was signed into law, creating federal rules to protect human research participants. The law was a direct response to the men who were mistreated in the study.

“We understand that history cannot be undone,” said Tyson Head. “We can construct bridges to trustworthiness and health care. By working together, we can make health equity a reality, dismantle racial and social injustices and advance biomedical research.”

Recently, the foundation met with NIH leadership to discuss how NIH could assist in uncovering the truths held within records that might be yet undiscovered, said Dr. Lyric Jorgenson, NIH’s associate director for science policy. NIH worked with the foundation to locate and preserve documents from the study.

“We are incredibly pleased that we could work with these leaders and help shed some additional light on this unjust effort so that we may never again repeat our past,” said Jorgenson.

Documents from the study are now publicly available on NLM’s website, said acting NLM Director Dr. Steven Sherry. Working closely with Fisk University, NLM digitized more than 3,000 records from the study. Examples of records include correspondence, meeting minutes, reports and scientific articles. Previously, these documents were only available in physical form.

“NLM’s stewardship of this collection supports our mission to enable biomedical research and support health care and public health through free online access to scholarly biomedical literature,” he said. “Our goal for this significant collection is to reach a broad audience and serve as a beacon of transparency with the biomedical and health care community.”

The National Research Act acknowledges the government’s past failures and commits health officials to a future where ethical principles are paramount to the conduct of research, said Department of Health and Human Services Assistant Secretary for Health ADM Rachel Levine in recorded remarks.

“The National Research Act is the U.S. government’s commitment to the American people that the pursuit of knowledge must not come at the cost of human dignity and human rights,” Levine concluded. She thanked everyone in attendance for partnering to ensure transparency and high ethical standards in research to create a healthier future for all who live in the U.S.

View the full collection of documents from the study at go.nih.gov/PCjiOXk.

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

How I Spent My Summer Vacation

I SPENT SOME TIME GETTING IN TOUCH WITH MY CREATIVE SIDE

This summer started off great for OSP from a creative standpoint.  First, we developed a new informed consent language resource to help the research community responsibly communicate about digital health technologies. Our creative juices were still flowing throughout July when we launched a new PartnersinResearch site that also includes 14 NIH Institute, Center, and Office case studies (and counting!) that researchers, patients, patient advocates, and caregivers can use to strengthen their own patient engagement approaches. Barreling into August we launched a new page on the OSP website that revisits NIH’s policy framework as it relates to advancing artificial intelligence to help researchers think through the implications of the development and use of this technology.

I MET SOME REALLY AMAZING NEW PEOPLE!

Recently, NIH Principal Deputy Director, Dr. Larry Tabak, OER Deputy Director, Dr. Liza Bundesen, and I had the honor of hosting the heads of 15 German research universities as part of a delegation visit to the US. It was so great to be able to share the NIH story with our international partners, which included discussions about how NIH makes funding decisions. As an extra bonus, they took a tour of our one of kind, state of the art research hospital, the NIH Clinical Center.  We heard that nothing like NIH exists in Germany, so I think they left impressed! We all promised to K.I.T.

Entering into the second year of the OSP summer internship (recently expanded to undergraduates), OSP hosted three amazingly talented interns who accomplished some really impressive projects – stay tuned for their stories. Details on how to apply for next summer’s internship will be posted to the OSP website in January 2025.

Finally, I was energized to meet with the policy professionals of tomorrow when I joined the NIH Oxford–Cambridge Scholars Program Annual Colloquium. Here, I shared about how I got engaged in science policy and hopefully imparted some nuggets of wisdom for navigating the trajectory!

I TOOK SOME TIME TO SIT BACK AND REALLY LISTEN

The best way to solve a problem is to ask for help from many, many different people!  This summer OSP asked for a lot of help, which you may have seen through our numerous requests for information on policy issues related to promoting equity in access planningraising public voices in clinical research, and public access to NIH-supported research findings. We are always immensely grateful for time people take to provide thought-provoking feedback, which can ultimately be found on the public comment page of the OSP Website once we’ve sorted through it all!

This summer we also hosted two listening sessions on issues we are really passionate about. The first session focused on NIH levers to promote access to NIH discoveries.  The second session was co-hosted with our fantastic partners at CISCRP and our NExTRAC ENGAGE leaders, and focused on hearing from individuals their perspectives on engagement in clinical research.

I ROCKED OUT TO SOME SWEET MUSIC

While I am an active concert goer, I was particularly excited about being among the invited guests to see the unveiling of Dr. Francis Collins’ NIH Director portrait.  Of course, if Dr. Collins is in attendance, there is an excellent chance that Rosalind (his guitar) will also be in the house. As you can see, Dr. Collins serenaded the audience, which included his wife Diane, former Senator Roy Blunt, former NIH Director Dr. Elias Zerhouni, current NIH Director, Dr. Monica Bertagnolli, several of the NIH Institute Directors and many others whose lives were touched by this inspirational leader.

I TOOK TIME FOR A REAL VACATION!!

As you might be able to tell, it was a busy summer. So much happened over this summer that I feel like it just flew by.  Thankfully, I did get a little bit of time to take a vacation to see friends, family, and Babe, the blue ox at Paul Buyan land. I truly hope you were able to also take some time to enjoy the summer as well! 

With summer now in the rearview mirror, I am excited to see what the fall brings. If the past is any indication, the fall will be a busy time here at NIH.  Some things to look forward to as we enter the last few months of 2024 include the next iteration of NIH’s annual bioethics supplement, the finalization of the numerous policies discussed above, community conversations related to the ENGAGE initiative, the meeting of the Advisory Committee to the NIH Director in December and much more. Feel free to share your summer pics with us as well!

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

Not A Blank Space: Policy Considerations for AI in Research

One of the hardest (and most fun) parts of my job is conjuring up my crystal ball to foresee the policy needs of tomorrow. Of course, forecasting the future isn’t really that easy. Technology moves at light speed, while policy… well, policy often moves slower (we can get into that in another blog).  How can we ready the biomedical research enterprise for the future when the future itself is a moving target?  Paradoxically, to quote Taylor Swift, “lookin’ backwards might be the only way to move forward.”

As policymakers, we are continuously striving to develop policies capable of evolving alongside science and technology, taking into consideration that we know there will be unexpected twists and turns along the way. This is why we built a certain degree of flexibility into the NIH Data Management and Sharing Policy – because new tools for creating, sharing, and accessing data are being developed every day.

This is especially the case for machine learning algorithms, natural language processing, and other forms of “artificial intelligence” that are creating new research opportunities and transforming a new wave of improved health outcomes. Artificial intelligence (AI) has been around in some shape or form for some time. However, the ease in which AI approaches can be developed and deployed (similar to what CRISPR did for gene editing) has leveled the playing field for researchers around the globe to find new patterns in rich and complex datasets.

Of course, with great power comes great responsibility. At NIH, we prioritize the safe and responsible development and use of algorithms and models for research. We also implement policies and practices to ensure deposition of AI-ready datasets that are reliable, representative, and robust. To achieve these aims, NIH relies on its forward-leaning policy infrastructure to safeguard our work. While these policies might not specifically state AI in the title, the anticipated use of AI and risks from those uses is what we intended to address. To help the research community understand how these policies guide AI-related research, OSP recently released a centralized NIH policy resource illustrating the applicability of existing policies to AI, including policies related to participant protections, intellectual property, peer review, and many other topics.

An important thing to keep in mind is that NIH’s current policy landscape is well positioned to ensure the responsible use of AI technologies. However, as a policy office, we know that sometimes new policies are indeed warranted to capture new risks as science and technology progresses.  NIH is committed to monitoring the field of AI and other emerging technologies and we will continue to update this resource to make sure we are keeping pace from a policy perspective. I invite you to check out this new resource and let us know your thoughts.  Research that leverages the most promising technologies in a responsible manner will lead to better health for all.  That is a future we can all hope for.

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

New Resources to Help Raise Community Voices in Clinical Research

Dr. Lyric Jorgenson has co-authored this blog with Dr. Joni Rutter (r). Dr. Rutter is the Director of the National Center for Advancing Translational Sciences (NCATS) within NIH.

Have you ever tried to put together a jigsaw puzzle without looking at the completed picture they include in the box?  How about trying to build a model airplane without consulting the step-by-step instructions?  Being able to see the end from the beginning helps guide the direction of what you are trying to build.  Without it, you are simply looking at individual pieces that might obscure the clarity of the big picture.  Just as these tools help guide assembly, case studies help guide understanding and implementation in clinical research.  This might be one of the reasons why so many people within the biomedical research community rely on (and request the development of) case studies as an educational resource to better understand policy matters.

When OSP recently announced the ENGAGE initiative, we immediately recognized an opportunity to provide practical, real-world examples of the many effective tools, strategies, and best practices of clinical research engagement being used by NIH’s Institutes and Centers. To be the most useful, a case study must present relatable problems, tangible results, and generalizable conclusions. Without these elements, the risk of your case study being seen as a “one-off” experience is magnified.  Fortunately, NIH has a wide body of experience to draw from to create case studies that would be useful to our research community. 

NIH has added a section to the ENGAGE website (PartnersinResearch.nih.gov) dedicated to presenting these tools, strategies, and best practices in case study form.  These case studies are aimed at three primary audiences:

  1. Patients, Caregivers, and Advocacy Groups: These stakeholders can benefit from understanding how to effectively collaborate with researchers in the development and oversight of clinical studies. The case studies provide practical examples of successful patient engagement, illustrating how active involvement can influence research outcomes and ensure that studies address the real-world needs and concerns of patients and their families.
  2. Community Members: Individuals can benefit from insights into the methods and importance of participating in clinical research. The case studies demonstrate how community involvement can enhance the relevance and cultural sensitivity of research, ensuring that the findings are more broadly applicable and beneficial to diverse populations. They also aim to empower community members to become active contributors to the research process. and
  3. Researchers and Research Teams: Members of these communities can benefit by learning how to integrate engagement strategies into their work. The  case studies provide evidence-based practices and models for fostering collaborative decision-making, equitable engagement, and sustainable capacity building within research programs. By learning from these examples, researchers can improve the design and implementation of their studies, ultimately enhancing the impact and ethical integrity of their work.

The case studies also cover five broad areas associated with clinical research engagement, including:

  • Collaborative Decision-Making
  • Equitable Engagement
  • Methods of Engagement
  • Sustainable Engagement & Capacity Building
  • Return of Research Value

The case studies cover a broad range of NIH resources, programs, and strategies.  For example, some of the case studies include materials to help patients and patient advocacy groups partner with scientists in the treatment development process, some describe models for integrating patients and community members into the oversight of research programs, and others describe strategies for creating institutional capacity to ensure that meaningful engagement is sustainable over time.

We encourage you to take a look!  Right now, there are 14 case studies available for use which can be accessed at https://partnersinresearch.nih.gov/case-studies/.  As the ENGAGE initiative continues, we plan to add more case studies that reflect the knowledge base we are building. NIH, through the ENGAGE Working Group, is working hard to ensure that all public voices are not only heard but meaningfully incorporated into NIH-supported clinical research. We hope you find these case studies useful as a first step in achieving that goal.

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric